2′-deoxy-2′-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck

We investigated changes on 2′-deoxy-2′-[18F]fluoro-D-glucose positron emission tomography ((18)FDG-PET), diffusion-weighted magnetic resonance imaging (DW-MRI), and choline spectroscopy as early markers of cetuximab activity in squamous cell carcinoma of the head and neck (SCCHN). SCCHN patient-deri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Mignion, Lionel, Schmitz, Sandra, Michoux, Nicolas, Caignet, Xavier, Goebbels, Rose-Marie, Bol, Anne, Neveu, Marie-Aline C., Grégoire, Vincent, Duprez, Thierry, Lhommel, Renaud, Amant, Fréderic, Hermans, Els, Jordan, Benedicte F., Machiels, Jean-Pascal
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033354/
https://ncbi.nlm.nih.gov/pubmed/29983881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25574
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados